Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000028 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 4, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
7,500
Total Value
$137,870.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Mar 3, 2026 | Exercise/Conversion | 2,500 | $14.50 | $36,250.00 | 100,494 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 3, 2026 | Sale | 2,300 | $40.56 | $93,288.00 | 98,194 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Mar 3, 2026 | Sale | 200 | $41.66 | $8,332.00 | 97,994 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Mar 3, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 402,357 | Direct | โ | View Details |